Filing Flows › TransMedics Group (TMDX) › Product revenue
TransMedics Group (TMDX) Product revenue by quarter
TransMedics Group's Product revenue was $113M in Q3 2026 (third quarter 2026), +2% from Q2 2026. Over the last 7 quarters it ranged from $87.7M (Q3 2025) to $113M (Q3 2026).
| Quarter | Product revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $113M | +2% | +29% |
| Q2 2026 | $111M | +3% | +16% |
| Q1 2026 | $108M | +8% | +22% |
| Q4 2025 | $100M | +14% | — |
| Q3 2025 | $87.7M | -9% | — |
| Q2 2025 | $96.1M | +9% | — |
| Q1 2025 | $88.2M | — | — |
Q3 2026 at a glance
TransMedics Group, Q3 2026: revenue $203M (+41% year over year), operating margin 13.9%, net earnings $17.1M, operating cash flow $36.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is TransMedics Group's Product revenue?
TransMedics Group's Product revenue was $113M in Q3 2026 (third quarter 2026), +2% from Q2 2026.
How has TransMedics Group's Product revenue changed?
Over the last 7 quarters it ranged from $87.7M (Q3 2025) to $113M (Q3 2026).